Growth Metrics

Erasca (ERAS) Cash & Equivalents (2020 - 2026)

Erasca posted quarterly Cash & Equivalents of $47.3 million for Q1 2026, down 32.95% year-on-year from $70.5 million in Q1 2025, and down 35.97% on a QoQ basis from $73.8 million in Q4 2025.

Erasca (ERAS) has 7 years of Cash & Equivalents data on file, last reported at $47.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash & Equivalents fell 32.95% year-over-year to $47.3 million; the trailing twelve-month figure through Mar 2026 stood at $47.3 million (down 32.95% YoY), and the FY2025 full-year result was $73.8 million, up 8.95% from the prior year.
  • Cash & Equivalents for Q1 2026 stood at $47.3 million, down from $73.8 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $333.3 million in Q1 2022 and bottomed at $47.3 million in Q1 2026.
  • The 5-year median for Cash & Equivalents is $112.9 million (2023), against an average of $146.1 million.
  • The widest annual swing landed in 2022, when Cash & Equivalents jumped 96.1%; it then plunged 67.25% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $284.2 million in 2022, then slumped by 67.25% to $93.1 million in 2023, then retreated by 27.22% to $67.7 million in 2024, then rose by 8.95% to $73.8 million in 2025, then plunged by 35.97% to $47.3 million in 2026.
  • The last three Cash & Equivalents figures came in at $47.3 million (Q1 2026), $73.8 million (Q4 2025), and $70.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 1.91 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 32.30 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 286.70 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 61.46 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 2.77 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 5.49 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - 18.44 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 2.96 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.71 Bn
10 Erasca 4.21 Bn 3.97 Bn - 47.26 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 47.26 Mn
Dec 31, 2025 73.81 Mn
Sep 30, 2025 70.23 Mn
Jun 30, 2025 66.14 Mn
Mar 31, 2025 70.48 Mn
Dec 31, 2024 67.74 Mn
Sep 30, 2024 68.89 Mn
Jun 30, 2024 172.80 Mn
Mar 31, 2024 172.80 Mn
Dec 31, 2023 93.08 Mn
Sep 30, 2023 112.86 Mn
Jun 30, 2023 138.79 Mn
Mar 31, 2023 272.76 Mn
Dec 31, 2022 284.22 Mn
Sep 30, 2022 219.26 Mn
Jun 30, 2022 219.26 Mn
Mar 31, 2022 333.35 Mn
Dec 31, 2021 360.49 Mn
Sep 30, 2021 445.81 Mn
Jun 30, 2021 156.40 Mn
Mar 31, 2021 169.99 Mn
Dec 31, 2020 65.38 Mn
Sep 30, 2020 62.02 Mn
Jun 30, 2020 104.34 Mn